Effectiveness of roflumilast, a phosphodiesterase type-4 (PDE4) inhibitor on biomarkers of inflammation in COPD

被引：0
|
作者：
Savelikhina, Iryna [1 ]
Ostrovskyy, Mykola [1 ]
Zuban, Alla [1 ]
Varunkiv, Oleksandr [1 ]
Kulynych-Miskiv, Mariana [1 ]
Shvets, Kostiantyn [1 ]
Korzh, Galyna [1 ]
Makoyda, Iryna [1 ]
Korzh, Nadiia [1 ]
Shevchuk-Budz, Uliana [1 ]
机构：
[1] Ivano Frankivsk Natl Med Univ, Ivano Frankivsk, Ukraine
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA1306
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors
    Miguel Perez-Aso
    M. Carmen Montesinos
    Aránzazu Mediero
    Tuere Wilder
    Peter H. Schafer
    Bruce Cronstein
    Arthritis Research & Therapy, 17
  • [32] Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors
    Perez-Aso, Miguel
    Montesinos, M. Carmen
    Mediero, Aranzazu
    Wilder, Tuere
    Schafer, Peter H.
    Cronstein, Bruce
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [33] Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors
    Wollin, L.
    Bundschuh, D. S.
    Wohlsen, A.
    Marx, D.
    Beume, R.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2006, 19 (05) : 343 - 352
  • [34] Preliminary evidence for the phosphodiesterase type-4 inhibitor, roflumilast, in ameliorating cognitive flexibility deficits in patients with schizophrenia
    Livingston, Nicholas R.
    Hawkins, Peter C. T.
    Gilleen, James
    Ye, Rong
    Valdearenas, Lorena
    Shergill, Sukhi S.
    Mehta, Mitul A.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2021, 35 (09) : 1099 - 1110
  • [35] Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of Exacerbations
    Field, Stephen K.
    CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE, 2011, 5 : 57 - 70
  • [36] A ROLE FOR PHOSPHODIESTERASE TYPE 4 (PDE4) IN BINGE-LIKE DRINKING
    Ozburn, A. R.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 97A - 97A
  • [37] Phosphodiesterase 4 (PDE4) Inhibitors in the Treatment of COPD: Promising Drug Candidates and Future Directions
    Parikh, Naisargee
    Chakraborti, Asit K.
    CURRENT MEDICINAL CHEMISTRY, 2016, 23 (02) : 129 - 141
  • [38] Novel Roflumilast analogs as soft PDE4 inhibitors
    Boland, Sandro
    Alen, Jo
    Bourin, Arnaud
    Castermans, Karolien
    Boumans, Nicki
    Panitti, Laura
    Vanormelingen, Jessica
    Leysen, Dirk
    Defert, Olivier
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (18) : 4594 - 4597
  • [39] Roflumilast: A selective phosphodiesterase 4 inhibitor
    Christie, P
    DRUGS OF TODAY, 2005, 41 (10): : 667 - 675
  • [40] Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro
    Hatzelmann, A
    Schudt, C
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 297 (01): : 267 - 279
12345